A. V. Zahrebelska
A. V. Zahrebelska has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ye. V. Titov2 shared publications
- A. K. Zhuravlyova
Харківський національний медичний університет
1 shared publication - Andrii Antonov
Донецький національний медичний університет, м. Кропивницький
1 shared publication - D. Kiriya
Kharkiv National Medical University
1 shared publication - H. P. Zinchenko1 shared publication
- I. I. Yakovtsova
Kharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, Ukraine
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Publishing Company VIT-A-POL in Ukrainian Therapeutical Journal
- No. 2,p. 60-69
Systemic manifestations of porphyria cutanea tarda against the background of liver cirrhosis: literature review and case report
Porphyria cutanea tarda (PCT) is a metabolic disorder caused by a deficiency in uroporphyrinogen decarboxylase, leading to systemic porphyrin deposition. The diagnosis of PCT in the setting of decompensated liver cirrhosis is significantly challenging due to clinical mimicry of systemic connective tissue diseases or secondary hemochromatosis, creating a «metabolic trap» for clinicians. We present a clinical analysis of a 55- year-old female patient with a history of photosensitivity and progressive liver failure of unknown etiology. The clinical course was characterized by severe pancytopenia (Hb 67 g/L, platelets 61 · 109/L), hepatosplenomegaly, and sepsis (Staphylococcus hominis). Laboratory findings revealed a profound biochemical dissociation: extreme hyperferritinemia (760 ng/mL) with normal serum iron levels, and an absence of hyperbilirubinemia (17.4 µmol/L). Urinary porphyrins remained at the upper limit of normal despite systemic involvement. The detection of myositis-specific antibodies (anti-PL-7, anti-Ro52) initially directed the diagnostic search toward antisynthetase syndrome. The patient died on the 14th day of hospitalization due to fulminant disseminated intravascular coagulation and pulmonary embolism (D-dimer > 7500 ng/mL). Autopsy verified an atypical grayish-green discoloration of the liver, pancreas, and brain. However, Perls’ Prussian blue stain for iron was negative, confirming the porphyrinic nature of the pigmentation and excluding hemochromatosis. Histological analysis confirmed micronodular cirrhosis with hyaline droplet degeneration of hepatocytes in the absence of alcoholic steatosis. This case illustrates the phenomenon of «immunological mimicry,» where systemic necrobiosis of hepatocytes triggers the release of intracellular antigens, leading to false-positive rheumatological tests. The metabolic dissociation (normal bilirubin and urinary porphyrin levels despite massive organ pigmentation) is explained by the effect of tissue retention and limited their synthesis at early stages. A negative Perls’ reaction is a critical differential marker that distinguishes «pseudo-hemochromatosis» in PCT patients from iron-overload diseases. Conclusions. Clinicians should maintain a high index of suspicion for PCT in patients with cirrhosis of unknown etiology presenting with skin lesions, even in the absence of classic biochemical markers in urine and blood. Histochemical verification is an essential step in identifying systemic porphyrinosis and avoiding diagnostic errors driven by rheumatological «masks».
- 30 June 2026
- Published by Publishing Company VIT-A-POL in Ukrainian Therapeutical Journal
- No. 2,p. 60-69
Open AccessSystemic manifestations of porphyria cutanea tarda against the background of liver cirrhosis: literature review and case report
Porphyria cutanea tarda (PCT) is a metabolic disorder caused by a deficiency in uroporphyrinogen decarboxylase, leading to systemic porphyrin deposition. The diagnosis of PCT in the setting of decompensated liver cirrhosis is significantly challenging due to clinical mimicry of systemic connective tissue diseases or secondary hemochromatosis, creating a «metabolic trap» for clinicians. We present a clinical analysis of a 55- year-old female patient with a history of photosensitivity and progressive liver failure of unknown etiology. The clinical course was characterized by severe pancytopenia (Hb 67 g/L, platelets 61 · 109/L), hepatosplenomegaly, and sepsis (Staphylococcus hominis). Laboratory findings revealed a profound biochemical dissociation: extreme hyperferritinemia (760 ng/mL) with normal serum iron levels, and an absence of hyperbilirubinemia (17.4 µmol/L). Urinary porphyrins remained at the upper limit of normal despite systemic involvement. The detection of myositis-specific antibodies (anti-PL-7, anti-Ro52) initially directed the diagnostic search toward antisynthetase syndrome. The patient died on the 14th day of hospitalization due to fulminant disseminated intravascular coagulation and pulmonary embolism (D-dimer > 7500 ng/mL). Autopsy verified an atypical grayish-green discoloration of the liver, pancreas, and brain. However, Perls’ Prussian blue stain for iron was negative, confirming the porphyrinic nature of the pigmentation and excluding hemochromatosis. Histological analysis confirmed micronodular cirrhosis with hyaline droplet degeneration of hepatocytes in the absence of alcoholic steatosis. This case illustrates the phenomenon of «immunological mimicry,» where systemic necrobiosis of hepatocytes triggers the release of intracellular antigens, leading to false-positive rheumatological tests. The metabolic dissociation (normal bilirubin and urinary porphyrin levels despite massive organ pigmentation) is explained by the effect of tissue retention and limited their synthesis at early stages. A negative Perls’ reaction is a critical differential marker that distinguishes «pseudo-hemochromatosis» in PCT patients from iron-overload diseases. Conclusions. Clinicians should maintain a high index of suspicion for PCT in patients with cirrhosis of unknown etiology presenting with skin lesions, even in the absence of classic biochemical markers in urine and blood. Histochemical verification is an essential step in identifying systemic porphyrinosis and avoiding diagnostic errors driven by rheumatological «masks».
- Open Access
- 15 June 2026
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 83 (2) , 71-76
NEUROENDOCRINE DISORDERS IN PRADER-WILLI SYNDROME: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE
Prader-Willi syndrome (PWS) is a rare genetic disease belonging to adjacent genes syndromes, caused by abnormal DNA methylation in the Prader-Willi critical region (PWCR) in 15q11.2-q13 region. Three main mechanisms are distinguished in its pathogenesis: genetic, molecular and physiological. The endocrine profile of PWS patients is characterized by polyglandular endocrinopathy: somatotropic insufficiency (90% of cases); hypogonadotropic hypogonadism with a possible combination with primary gonad lesions; central hypothyroidism. Special attention should be paid to latent adrenal insufficiency, which causes sudden death in stressful situations. The article presents a review of the current literature on the overall prevalence, mortality, pathogenesis, neuroendocrine disorders, modern diagnostic and therapeutic options. A systematic search of literature sources was carried out in the databases Scopus, PubMed, Web of Science, Embase, the Cochrane Library, MedLine.
- 15 June 2026
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 83 (2) , 71-76
Open AccessNEUROENDOCRINE DISORDERS IN PRADER-WILLI SYNDROME: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE
Prader-Willi syndrome (PWS) is a rare genetic disease belonging to adjacent genes syndromes, caused by abnormal DNA methylation in the Prader-Willi critical region (PWCR) in 15q11.2-q13 region. Three main mechanisms are distinguished in its pathogenesis: genetic, molecular and physiological. The endocrine profile of PWS patients is characterized by polyglandular endocrinopathy: somatotropic insufficiency (90% of cases); hypogonadotropic hypogonadism with a possible combination with primary gonad lesions; central hypothyroidism. Special attention should be paid to latent adrenal insufficiency, which causes sudden death in stressful situations. The article presents a review of the current literature on the overall prevalence, mortality, pathogenesis, neuroendocrine disorders, modern diagnostic and therapeutic options. A systematic search of literature sources was carried out in the databases Scopus, PubMed, Web of Science, Embase, the Cochrane Library, MedLine.
- Open Access
- 27 March 2026
- Published by Dnipro State Medical University in Morphologia
- Vol. 20 (1)
Duchene’s muscular dystrophy: a clinical case
Background. Muscular dystrophy is a heterogeneous group of genetic disorders characterized by progressive loss of skeletal muscles. Duchene's muscular dystrophy (MDD) is one of the most common and pronounced forms of muscular dystrophy associated with the X chromosome on a recessive feature and belongs to the class “Dystrofinopathy”. Dystrophinopathy develops in the hereditary absence of a membrane protein of dystrophin, which is responsible for the integrity of the muscle cell cytoskeleton. MDD develops quite slowly and is asymptomatic at an early stage. In the subsequent course of the disease there are severe lesions of skeletal and respiratory muscles, heart, delayed psycho -language development and organic lesions of the nervous system. Multiple insufficiency in such patients causes high rates of early mortality. Aim. The purpose of the work is to describe a clinical case of a rare Duchene muscle dystrophy disease with a patient who was treated with a regional clinical hospital with a more detailed study of pathomorphological changes in this pathology. Methods. The material for the study was a clinical case of Duchene's muscular dystrophy in a patient who died in the Emergency Medical Assistance Department of the KNP Choir "Regional Clinical Hospital" in Kharkiv with a clinical diagnosis: Duchene's muscular dystrophy. The patient's medical history and the autopsy protocol were studied. Histological examination was performed using the following painting methods: hematoxylin-eosin, van Gizon, Congo red, Perls reaction. Results. Autopsy revealed the following pathomorphological changes: lesions of skeletal muscles - scoliosis, pseudogipertrophy of the calf muscles; respiratory damage and cardiomyopathy pathology, which have led to the development of decompensated right ventricular heart failure in the patient. Conclusion. MDD is a rare progressive disease that is inherited with dystrophin protein deficiency. Pathology occurs in early childhood and leads to muscle tissue. Most patients die from pulmonary - heart failure. In this case, the pathomorphological changes that occur in this disease are described.
- 27 March 2026
- Published by Dnipro State Medical University in Morphologia
- Vol. 20 (1)
Open AccessDuchene’s muscular dystrophy: a clinical case
Background. Muscular dystrophy is a heterogeneous group of genetic disorders characterized by progressive loss of skeletal muscles. Duchene's muscular dystrophy (MDD) is one of the most common and pronounced forms of muscular dystrophy associated with the X chromosome on a recessive feature and belongs to the class “Dystrofinopathy”. Dystrophinopathy develops in the hereditary absence of a membrane protein of dystrophin, which is responsible for the integrity of the muscle cell cytoskeleton. MDD develops quite slowly and is asymptomatic at an early stage. In the subsequent course of the disease there are severe lesions of skeletal and respiratory muscles, heart, delayed psycho -language development and organic lesions of the nervous system. Multiple insufficiency in such patients causes high rates of early mortality. Aim. The purpose of the work is to describe a clinical case of a rare Duchene muscle dystrophy disease with a patient who was treated with a regional clinical hospital with a more detailed study of pathomorphological changes in this pathology. Methods. The material for the study was a clinical case of Duchene's muscular dystrophy in a patient who died in the Emergency Medical Assistance Department of the KNP Choir "Regional Clinical Hospital" in Kharkiv with a clinical diagnosis: Duchene's muscular dystrophy. The patient's medical history and the autopsy protocol were studied. Histological examination was performed using the following painting methods: hematoxylin-eosin, van Gizon, Congo red, Perls reaction. Results. Autopsy revealed the following pathomorphological changes: lesions of skeletal muscles - scoliosis, pseudogipertrophy of the calf muscles; respiratory damage and cardiomyopathy pathology, which have led to the development of decompensated right ventricular heart failure in the patient. Conclusion. MDD is a rare progressive disease that is inherited with dystrophin protein deficiency. Pathology occurs in early childhood and leads to muscle tissue. Most patients die from pulmonary - heart failure. In this case, the pathomorphological changes that occur in this disease are described.